Debasis Das

981 total citations
33 papers, 723 citations indexed

About

Debasis Das is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Debasis Das has authored 33 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Debasis Das's work include Quinazolinone synthesis and applications (6 papers), Synthesis and biological activity (5 papers) and Cyclopropane Reaction Mechanisms (5 papers). Debasis Das is often cited by papers focused on Quinazolinone synthesis and applications (6 papers), Synthesis and biological activity (5 papers) and Cyclopropane Reaction Mechanisms (5 papers). Debasis Das collaborates with scholars based in India, China and United States. Debasis Das's co-authors include Jian Hong, Saumitra Sengupta, Hong Jian, Md. Nasim Khan, Jingli Shi, Somnath Mondal, Swapan Kumar Biswas, Xin Xu, Zonghua Zhang and Shuhui Chen and has published in prestigious journals such as Tetrahedron Letters, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Debasis Das

29 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debasis Das India 14 471 228 113 72 65 33 723
Sung Yun Cho South Korea 15 277 0.6× 356 1.6× 115 1.0× 66 0.9× 48 0.7× 43 673
Youlu Pan China 14 219 0.5× 262 1.1× 122 1.1× 77 1.1× 21 0.3× 38 609
Yu-Shan Wu Taiwan 10 199 0.4× 281 1.2× 185 1.6× 26 0.4× 28 0.4× 10 644
Kiyoaki Sakata United States 14 320 0.7× 476 2.1× 166 1.5× 81 1.1× 17 0.3× 19 865
Nozomu Koyanagi Japan 12 571 1.2× 614 2.7× 247 2.2× 38 0.5× 43 0.7× 18 1.0k
Wufu Zhu China 24 727 1.5× 544 2.4× 153 1.4× 139 1.9× 68 1.0× 53 1.1k
R. Hendricks United States 12 240 0.5× 180 0.8× 148 1.3× 178 2.5× 31 0.5× 14 716
Yu Luo China 17 420 0.9× 519 2.3× 95 0.8× 22 0.3× 33 0.5× 58 969
Dongmei Zhao China 17 158 0.3× 255 1.1× 97 0.9× 22 0.3× 15 0.2× 46 705
Danny Hsu United States 12 184 0.4× 214 0.9× 117 1.0× 32 0.4× 13 0.2× 27 510

Countries citing papers authored by Debasis Das

Since Specialization
Citations

This map shows the geographic impact of Debasis Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debasis Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debasis Das more than expected).

Fields of papers citing papers by Debasis Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debasis Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debasis Das. The network helps show where Debasis Das may publish in the future.

Co-authorship network of co-authors of Debasis Das

This figure shows the co-authorship network connecting the top 25 collaborators of Debasis Das. A scholar is included among the top collaborators of Debasis Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debasis Das. Debasis Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Debasis, et al.. (2025). Discovery of Reversible, Noncovalent Bruton’s Tyrosine Kinase Inhibitors Targeting BTK C481S Mutation. ACS Medicinal Chemistry Letters. 16(6). 1038–1047.
2.
Majem, Margarita, Roger Keresztes, Yinjun Lou, et al.. (2024). LBA3 Perioperative pembrolizumab (pembro) plus neoadjuvant chemotherapy (chemo) in early-stage non-small-cell lung cancer (NSCLC): A 4-year update of KEYNOTE-671. Immuno-Oncology Technology. 24. 101027–101027.
3.
Das, Debasis, et al.. (2024). Next-generation EGFR tyrosine kinase inhibitors to overcome C797S mutation in non-small cell lung cancer (2019–2024). RSC Medicinal Chemistry. 15(10). 3371–3394. 24 indexed citations
4.
Das, Debasis, et al.. (2023). Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models. ACS Medicinal Chemistry Letters. 14(6). 727–736. 3 indexed citations
5.
Das, Debasis & Hong Jian. (2020). Recent Progress and Development of Small Molecule Kinase Inhibitors for the Treatment of Breast Cancer. Current Enzyme Inhibition. 16(1). 4–19. 6 indexed citations
6.
7.
Khan, Md. Nasim, et al.. (2020). Recent Applications of Azo Dyes: A Paradigm Shift from Medicinal Chemistry to Biomedical Sciences. Mini-Reviews in Medicinal Chemistry. 21(9). 1071–1084. 55 indexed citations
8.
Das, Debasis, et al.. (2020). Irreversible Kinase Inhibitors Targeting Cysteine Residues and their Applications in Cancer Therapy. Mini-Reviews in Medicinal Chemistry. 20(17). 1732–1753. 19 indexed citations
9.
Das, Debasis, et al.. (2019). Disability in new leprosy cases-magnitude, pattern and associated factors: a cross sectional study in a subdivision of Darjeeling district, West Bengal.. 91(3). 207–215. 1 indexed citations
10.
11.
Das, Debasis & Jian Hong. (2019). Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. European Journal of Medicinal Chemistry. 170. 55–72. 78 indexed citations
12.
Das, Debasis, et al.. (2018). Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities – Part 1. Bioorganic & Medicinal Chemistry Letters. 29(4). 591–596. 49 indexed citations
13.
Das, Debasis, et al.. (2015). Recent developments of 2-aminothiazoles in medicinal chemistry. European Journal of Medicinal Chemistry. 109. 89–98. 182 indexed citations
14.
Das, Debasis, Jian Hong, Shuhui Chen, et al.. (2011). Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry. 19(16). 4690–4703. 26 indexed citations
15.
Das, Debasis, et al.. (2009). Application of Modern Techniques in Characterization and Management of Soil and Water Resources. Journal of the Indian Society of Soil Science. 57(4). 445–460. 7 indexed citations
16.
Wang, Guangyi, Xiaomin Wu, Debasis Das, et al.. (2009). HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives. Bioorganic & Medicinal Chemistry Letters. 19(15). 4484–4487. 8 indexed citations
17.
Wang, Guangyi, Yanzhen He, Debasis Das, et al.. (2009). HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives. Bioorganic & Medicinal Chemistry Letters. 19(15). 4476–4479. 15 indexed citations
18.
Sengupta, Saumitra & Debasis Das. (2000). Intermolecular O-H Insertion Reactions of l-Tartrate Derived α-Diazo Ketones: Synthesis of Xylulose Derivatives. Synthesis. 2000(3). 352–354.
19.
Sengupta, Saumitra, et al.. (1999). Stereoselective reduction of N-phthaloyl α-amino ketones: an expeditious new synthesis of non-racemic threo-α-amino epoxides. Tetrahedron Asymmetry. 10(9). 1653–1659. 6 indexed citations
20.
Sengupta, Saumitra, Somnath Mondal, & Debasis Das. (1999). Amino acid derived morpholine amides for nucleophilic α-amino acylation reactions: A new synthetic route to enantiopure α-amino ketones. Tetrahedron Letters. 40(21). 4107–4110. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung Yun Cho Breakdown of academic impact, for papers by Youlu Pan Breakdown of academic impact, for papers by Yu-Shan Wu Breakdown of academic impact, for papers by Kiyoaki Sakata Breakdown of academic impact, for papers by Nozomu Koyanagi Breakdown of academic impact, for papers by Wufu Zhu Breakdown of academic impact, for papers by R. Hendricks Breakdown of academic impact, for papers by Yu Luo Breakdown of academic impact, for papers by Dongmei Zhao Breakdown of academic impact, for papers by Danny Hsu
Rankless by CCL
2026